Ann: EYE February sales update, page-10

I'm guessing the market was previously using Europe sales as a forward indicator for US sales growth, given iTrack Advance was approved there first. It saw the immediate growth in Europe post approval quickly flatten, so it must have assumed the same would happen in the US (forgetting the fact that they weren't investing any resources in growth outside the USA). I'd say this announcement has definitely confirmed the sales growth we have seen isn't one off, and will be sustained for many years to come. Now that they are doubling their sales force I'm sure Sight Sciences are becoming quite concerned, and I'm sure other larger companies may be considering M&A options involving iTrack Advance, given its market leading status.